Brilliant Healthcare LtdPartnership
AAGH partners with Brilliant Healthcare Ltd, a Hong Kong-based company committed to providing excellent healthcare services with innovative technology and personalized health management systems.
Room 405, 4/F, Nan Fung Commercial Center
19 Lam Lok Street, Kowloon Bay, Hong Kong
About Brilliant Healthcare Ltd
A pioneering company in regenerative medicine with revolutionary patented technology for wound healing and anti-aging treatments.
Leadership & Innovation
Founded by Dr. Guo Aihua, a double doctor of plastic surgery and transplantation immunology. Dr. Guo developed the patented mini skin technology, which is the only in vitro synthetic and transplantable active organ containing stem cell germinal layer in the field of international regenerative medicine.
During the 2020 pandemic, Brilliant Healthcare was actively involved in introducing and distributing COVID-related products in Hong Kong and countries across Europe, South America, and North America, helping complete registration through local partnerships.
Joint Venture Agreement
On December 7th, 2020, America Great Health (California Corporation) entered into a cooperation agreement with Brilliant Healthcare Limited to establish a joint venture in China.
Mini Skin Structure Patent
Revolutionary patented technology that transforms wound healing from passive to active repair mechanisms using stem cell technology.
Patent Details
Patent Name:
The preparation and clinical application for a Mini skin structure
Patent Number:
ZL201010188002.X
Patentee & Inventor:
Dr. Aihua Guo
Patent Value:
USD $50-59 million (December 2020)
Technology Overview
The invention involves a mini skin structure integrated in vitro by epidermal cells and dermal cells, its preparation, and clinical application in regenerative medicine and the aesthetic industry.
This technology completely changes wound healing from traditional passive healing to an active healing mechanism where stem cells differentiate into fibroblast and epidermal cells, dominating the healing process.
Technology Advantages
Clinical Applications
Three major therapeutic applications targeting large and growing markets with proven technology readiness.
Wound Healing
Treatment of patients with burns, open wounds, and diabetic ulcers using active stem cell repair mechanisms instead of traditional passive healing methods.
Facial Anti-Aging Treatments
Stem cell-enriched technology that produces stronger collagen and cytokines formation, providing robust tissue repair compared to single fibroblast injections.
Hair Regeneration
In vivo hair follicle production using dermal sheath cells and epidermal cells, capable of producing human hair in animal models.
Market Valuation
The three main applications have been independently valued at CNY 387 million, equivalent to approximately USD $59 million at current exchange rates.
Technology for wound healing and anti-aging applications is considered fully developed, while hair treatment requires further optimization of treatment conditions and carrier ratios.
Key Facts & Achievements
Future Applications
Beyond therapeutic applications, this technology is expected to be used for basic clinical research, pharmaceutical drug screening, cosmetics testing, and disease modeling globally.
The technology holds several advantages due to its innovativeness, uniqueness, practicability, versatility, immuno-privilege, and authenticity.